封面
市场调查报告书
商品编码
1935301

语音生物标记市场按治疗用途、最终用户和地区划分

Vocal Biomarkers Market, By Therapeutic Application, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 152 Pages | 商品交期: 2-3个工作天内

价格
简介目录

预计到 2026 年,语音生物标记市场价值将达到 37.168 亿美元,到 2033 年将达到 101.687 亿美元,2026 年至 2033 年的复合年增长率为 15.5%。

报告内容 报告详情
基准年: 2025 2026年市场规模: 37.168亿美元
历史数据时期: 2020年至2024年 预测期: 2026年至2033年
预测期(2026-2033年)复合年增长率: 15.50% 2033 年的预测值: 101.687亿美元

语音可以作为一种有效的工具,用于识别忧郁症、帕金森氏症和冠状动脉疾病等疾病的存在及其风险。此外,从事语音技术研究的机构和公司正在合作寻找语音生物标记物,以辅助疾病的精准诊断。语音生物标记技术有望成为医学诊断领域的开创性创新,使检测慢性疾病的微创诊断程序成为可能。例如,Beyond Verbal, Inc.、Cogito Corporation 和 Sonde Health 等公司正在开发基于语音的平台,用于诊断身心健康状况。

市场动态

语音生物标记技术有望彻底改变我们诊断身心健康的方式,并革新整个医疗保健产业。这项以语音为基础的技术能够实现早期诊断和预防性治疗,帮助医院、诊所和个人监测自身健康状况并采取适当的医疗措施。

主要企业正致力于透过合作来巩固市场地位并强化产品系列,这有望推动市场成长。例如,2016年6月,Sonde Health Inc.从麻省理工学院林肯实验室获得了一项技术许可,用于开发一种基于语音的技术平台,该平台旨在监测和诊断各种身心疾病。此外,2016年,Beyond Verbal, Inc.与梅奥诊所合作,研究并识别可用于诊断身心健康的语音生物标记。

本次调查的主要特点

  • 本报告对全球语音生物标记市场进行了详细分析,并以 2025 年为基准年,给出了预测期(2026-2033 年)的市场规模和復合年增长率(%)。
  • 该报告还重点介绍了各个细分市场的潜在商机,并概述了该市场具有吸引力的投资提案矩阵。
  • 该研究还提供了有关市场驱动因素、限制因素、机会、新产品发布或核准、市场趋势、区域展望以及主要参与者采取的竞争策略的重要见解。
  • 本报告根据以下参数介绍了全球语音生物标记市场主要企业的概况:公司概况、财务表现、产品系列、市场地位、分销策略、主要发展、策略和未来计划。
  • 本报告的研究结果将帮助负责人和经营团队就即将推出的产品、技术升级、市场扩张和行销策略做出明智的决策。
  • 这份全球语音生物标记市场报告针对该行业的各种相关人员,包括投资者、供应商、产品製造商、经销商、新参与企业和金融分析师。
  • 相关人员可以透过语音生物标誌物市场分析中使用的各种策略矩阵轻鬆做出决策。

目录

第一章 研究目标与前提条件

  • 调查目的
  • 先决条件
  • 简称

第二章 市场范围

  • 报告概述
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map(COM)

第三章 市场动态、监管与趋势分析

  • 市场动态
    • 司机
    • 抑制因素
    • PEST分析
    • 波特五力分析
    • 市场机会
    • 法规环境
    • 重大进展
    • 产业趋势

4. 2026-2033年全球语音生物标记市场(依治疗应用划分)

  • 精神疾病
  • 呼吸系统疾病
  • 心血管疾病

5. 2026-2033年全球语音生物标记市场(依最终用户划分)

  • 医院
  • 健康保险公司
  • 学术和研究机构
  • 政府机构

6. 2026-2033年全球语音生物标记市场(按地区划分)

  • 北美洲
    • 我们
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 墨西哥
    • 其他拉丁美洲国家
  • 欧洲
    • 英国
    • 德国
    • 义大利
    • 法国
    • 西班牙
    • 俄罗斯
    • 其他欧洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • ASEAN
    • 澳洲
    • 韩国
    • 亚太其他地区
  • 中东
    • 海湾合作委员会国家
    • 以色列
    • 其他中东国家
  • 非洲
    • 南非
    • 北非
    • 中非

第七章 竞争情势

  • 热图分析
  • 市占率分析(3x3矩阵)
  • 公司简介
    • Beyond Verbal, Inc.
    • Sonde Health Inc.
    • Sharecare, Inc.
    • IBM Corporation
    • Cogito Corporation
    • AudEERING
    • VoiceSense
    • Winterlight Labs
    • Ellipsis Health
    • Vocalis Health

第八章 分析师建议

  • 机器
  • 分析师观点
  • Coherent Opportunity Map

第九章各节

  • 参考
  • 调查方法
简介目录
Product Code: CMI101

Vocal Biomarkers Market is estimated to be valued at USD 3,716.8 Mn in 2026 and is expected to reach USD 10,168.7 Mn by 2033, growing at a compound annual growth rate (CAGR) of 15.5% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 3,716.8 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 15.50% 2033 Value Projection: USD 10,168.7 Mn

Voice can serve as a useful tool in identifying the presence or risk of conditions such as depression, Parkinson's disease, and coronary artery disease. Moreover, Research institutes and companies engaged in voice and speech technology are partnering to identify vocal biomarkers that can aid in accurate disease diagnosis. Vocal biomarkers technology could be an advanced innovation in the field of medical diagnostics, allowing for minimally-invasive diagnostic procedures to detect chronic conditions. For instance, Beyond Verbal, Inc., Cogito Corporation, and Sonde Health are developing a voice-based platform to diagnose mental and physical health.

Market Dynamics

The vocal biomarkers technology would transform the way mental and physical health is diagnosed and would transform the healthcare industry. This voice-based technology would allow early diagnosis and preventive treatments. This is expected to benefit hospitals, health clinics, and individuals to monitor health condition and take appropriate medical action.

Key players are focused on collaborations, in order to gain strong foothold in the market and enhance their product portfolio which is expected to drive the market growth. For instance, in June 2016, Sonde Health Inc., obtained technology license from the Massachusetts Institute of Technology Lincoln Laboratory for the latter's voice-based technology platform intended for monitoring and diagnosing various mental and physical conditions. Moreover, Beyond Verbal, Inc. collaborated with Mayo Clinic in 2016 to conduct studies and identify vocal biomarkers that could help in diagnosing mental and physical health.

Key features of the study

  • This report provides in-depth analysis of the global vocal biomarkers market and provides market size (USD Mn) and compound annual growth rate (CAGR %) for the forecast period (2026 - 2033), considering 2025 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the global vocal biomarkers market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Beyond Verbal, Inc., Sonde Health Inc., Sharecare, Inc., IBM Corporation, and Cogito Corporation
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology upgradation, market expansion, and marketing tactics.
  • The global vocal biomarkers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the vocal biomarkers market

Market Segmentation

  • Therapeutic Application Insights (Revenue, USD Mn, 2026 - 2033)
    • Psychological Disorders
    • Respiratory Disorders
    • Cardiovascular Disorders
  • End User Insights (Revenue, USD Mn, 2026 - 2033)
    • Hospitals
    • Health Insurers
    • Academic & Research Institutions
    • Government Organizations
  • Regional Insights (Revenue, USD Mn, 2026 - 2033)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Beyond Verbal, Inc.
    • Sonde Health Inc.
    • Sharecare, Inc.
    • IBM Corporation
    • Cogito Corporation
    • AudEERING
    • VoiceSense
    • Winterlight Labs
    • Ellipsis Health
    • Vocalis Health

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Therapeutic Application
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • PEST Analysis
    • PORTER's Five Forces Analysis
    • Market Opportunities
    • Regulatory Scenario
    • Key Developments
    • Industry Trend

4. Global Vocal Biomarkers Market, By Therapeutic Application, 2026-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Psychological Disorders
    • Market Share Analysis, 2026, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Respiratory Disorders
    • Market Share Analysis, 2026, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Cardiovascular Disorders
    • Market Share Analysis, 2026, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends

5. Global Vocal Biomarkers Market, By End User, 2026-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Hospitals
    • Market Share Analysis, 2026, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Health Insurers
    • Market Share Analysis, 2026, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Academic & Research Institutions
    • Market Share Analysis, 2026, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Government Organizations
    • Market Share Analysis, 2026, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends

6. Global Vocal Biomarkers Market, By Region, 2026-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, By Region, 2026, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, For Region, 2021 - 2033
  • North America
    • Market Share Analysis, By Country, 2026, 2028 and 2033 (%)
    • Y-o-Y Growth Analysis, For Country, 2021 - 2033
    • Market Size and Forecast, By Therapeutic Application, 2026- 2033, (USD Mn)
    • Market Size and Forecast, By End User, 2026- 2033, (USD Mn)
    • Market Size and Forecast, By Country, 2026- 2033, (USD Mn)
      • U.S.
      • Canada
  • Latin America
    • Market Share Analysis, By Country, 2026, 2028 and 2033 (%)
    • Y-o-Y Growth Analysis, For Country, 2021 - 2033
    • Market Size and Forecast, By Therapeutic Application, 2026- 2033, (USD Mn)
    • Market Size and Forecast, By End User, 2026- 2033, (USD Mn)
    • Market Size and Forecast, By Country, 2026- 2033, (USD Mn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Market Share Analysis, By Country, 2026, 2028 and 2033 (%)
    • Y-o-Y Growth Analysis, For Country, 2021 - 2033
    • Market Size and Forecast, By Therapeutic Application, 2026- 2033, (USD Mn)
    • Market Size and Forecast, By End User, 2026- 2033, (USD Mn)
    • Market Size and Forecast, By Country, 2026- 2033, (USD Mn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Market Share Analysis, By Country, 2026, 2028 and 2033 (%)
    • Y-o-Y Growth Analysis, For Country, 2021 - 2033
    • Market Size and Forecast, By Therapeutic Application, 2026- 2033, (USD Mn)
    • Market Size and Forecast, By End User, 2026- 2033, (USD Mn)
    • Market Size and Forecast, By Country, 2026- 2033, (USD Mn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Market Share Analysis, By Country, 2026, 2028 and 2033 (%)
    • Y-o-Y Growth Analysis, For Country, 2021 - 2033
    • Market Size and Forecast, By Therapeutic Application, 2026- 2033, (USD Mn)
    • Market Size and Forecast, By End User, 2026- 2033, (USD Mn)
    • Market Size and Forecast, By Country, 2026- 2033, (USD Mn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Market Share Analysis, By Country/Region, 2026, 2028 and 2033 (%)
    • Y-o-Y Growth Analysis, For Country/Region, 2021 - 2033
    • Market Size and Forecast, By Therapeutic Application, 2026- 2033, (USD Mn)
    • Market Size and Forecast, By End User, 2026- 2033, (USD Mn)
    • Market Size and Forecast, By Country, 2026- 2033, (USD Mn)
      • South Africa
      • North Africa
      • Central Africa

7. Competitive Landscape

  • Heat Map Analysis
  • Market Share Analysis (3x3 Matrix)
  • Company Profiles
    • Beyond Verbal, Inc.
      • Company Overview
      • Product Type Portfolio
      • Recent Developments/Updates
    • Sonde Health Inc.
      • Company Overview
      • Product Type Portfolio
      • Recent Developments/Updates
    • Sharecare, Inc.
      • Company Overview
      • Product Type Portfolio
      • Recent Developments/Updates
    • IBM Corporation
      • Company Overview
      • Product Type Portfolio
      • Recent Developments/Updates
    • Cogito Corporation
      • Company Overview
      • Product Type Portfolio
      • Recent Developments/Updates
    • AudEERING
      • Company Overview
      • Product Type Portfolio
      • Recent Developments/Updates
    • VoiceSense
      • Company Overview
      • Product Type Portfolio
      • Recent Developments/Updates
    • Winterlight Labs
      • Company Overview
      • Product Type Portfolio
      • Recent Developments/Updates
    • Ellipsis Health
      • Company Overview
      • Product Type Portfolio
      • Recent Developments/Updates
    • Vocalis Health
      • Company Overview
      • Product Type Portfolio
      • Recent Developments/Updates

8. Analyst Recommendation

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

9. Section

  • References
  • Research Methodology
  • About Us and Sales Contact